Redmile Group, LLC Annexon, Inc. Transaction History
Redmile Group, LLC
- $822 Million
- Q2 2025
A detailed history of Redmile Group, LLC transactions in Annexon, Inc. stock. As of the latest transaction made, Redmile Group, LLC holds 6,300,644 shares of ANNX stock, worth $19.8 Million. This represents 1.84% of its overall portfolio holdings.
Number of Shares
6,300,644
Previous 6,300,644
-0.0%
Holding current value
$19.8 Million
Previous $12.2 Million
24.35%
% of portfolio
1.84%
Previous 1.28%
Shares
11 transactions
Others Institutions Holding ANNX
# of Institutions
140Shares Held
96.5MCall Options Held
0Put Options Held
63.4K-
Satter Management Co., L.P.7.41MShares$23.3 Million71.99% of portfolio
-
Bvf Inc San Francisco, CA7MShares$22.1 Million0.66% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$20.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.37MShares$16.9 Million0.0% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA5.25MShares$16.5 Million3.78% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $150M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...